Benjamin Benhuri

Benjamin Benhuri practices at NYU Langone - Tisch Hospital in New York, New York.

Benjamin Benhuri's NPI, 1376031690, was assigned on April 23, 2018. Benjamin Benhuri holds New York license 313632.

Benjamin Benhuri's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Benjamin Benhuri's primary practice is NYU Langone - Tisch Hospital in New York, New York. Benjamin Benhuri is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Benjamin Benhuri to 2 more group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Benjamin Benhuri practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Benjamin Benhuri's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Benjamin Benhuri is licensed in New York.

CMS data shows 695 Medicare services from Benjamin Benhuri across 8 procedure codes in 2024, for 116 Medicare patients. Medicare paid $36,587 for them. Every service was in an office.

CMS counts 116 Medicare patients who saw Benjamin Benhuri in 2024. The largest group is 65 to 74, with 58 patients. 66% of them have high cholesterol, and 59% have high blood pressure. 26% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Benjamin Benhuri's median patient age at 45, with 41% women.

In 2024, Benjamin Benhuri wrote 2,010 Medicare Part D claims for 174 patients. 77% of them were for generic drugs. CMS names the drug for 1,338 of them, across 50 drugs with 11 or more claims each, at $235,180 in total drug cost. In 2023, CMS named 519 claims across 25 drugs.

Benjamin Benhuri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Benjamin Benhuri as offering telehealth.

Dmand AI links 8 papers to Benjamin Benhuri, published from 2016 to 2022. 2019 was the busiest year, with 2. The most frequent topics are Antineoplastic Agents, Coronary Angiography and Nivolumab. Benjamin Benhuri's most frequent co-authors are Annapoorna S. Kini, MD, Samin Sharma, MD and Usman Baber, MD.

CMS Open Payments shows 71 general payments to Benjamin Benhuri from 15 drug and device companies from 2022 to 2025. Speaker and faculty fees make up the largest share, 63% of the total. Pfizer Inc. paid the most, $2,720.